Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alere launches pre-eclampsia test in Europe and Australia

This article was originally published in Clinica

Executive Summary

The Alere Triage PLGF test, which is designed to detect early-onset pre-eclampsia in pregnant women, is now available in Europe and Australia. Pre-eclampsia involves hypertension and protein in the urine and is a leading cause of maternal and foetal death worldwide. Traditional diagnosis using blood pressure and urine protein level measurements is non-specific, and these symptoms are not always present in women who develop serious complications. Measuring placental growth factor (PLGF) could provide a more sensitive and specific method of detecting the condition, as low maternal plasma levels have been linked with pre-eclampsia. Alere’s PLGF test, which it CE marked in September 2009, runs on the firm’s Triage MeterPro and provides results within 15 minutes. PerkinElmer also markets a pre-eclampsia test in Europe, called the DELFIA Xpress PlGF Assay, which it launched there in October (www.clinica.co.uk, 29 October 2010). No head-to-head studies of Alere's and PerkinElmer's test have been carried out, but Alere told Clinica: "Compared to other new tests, the Triage PLGF assay does not require an expensive analyser and can potentially be performed in a point-of-care setting."

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096412

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel